UK markets closed
NIKKEI 225
39,069.68 +282.30 (+0.73%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.65 -0.15 (-0.19%) GOLD FUTURES
2,432.50 -6.00 (-0.25%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
54,801.49 +2,605.08 (+4.99%)
Sumitomo Dainippon Pharma Co., Ltd. (DPM.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 790.49M |
| Enterprise value | 3.06B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.42 |
| Price/book (mrq) | 0.84 |
| Enterprise value/revenue | 1.64 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.59 |
| 52-week change 3 | -57.42% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 4.6200 |
| 52-week low 3 | 1.9500 |
| 50-day moving average 3 | 2.3378 |
| 200-day moving average 3 | 2.7399 |
Share statistics
| Avg vol (3-month) 3 | 48 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 397.29M |
| Implied shares outstanding 6 | 405.38M |
| Float 8 | 179.4M |
| % held by insiders 1 | 57.59% |
| % held by institutions 1 | 16.67% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.09 |
| Forward annual dividend yield 4 | 3.73% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 2.25 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 Mar 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -100.13% |
| Operating margin (ttm) | -298.49% |
Management effectiveness
| Return on assets (ttm) | -21.74% |
| Return on equity (ttm) | -111.89% |
Income statement
| Revenue (ttm) | 314.56B |
| Revenue per share (ttm) | 791.76 |
| Quarterly revenue growth (yoy) | -16.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -317.37B |
| Net income avi to common (ttm) | -314.97B |
| Diluted EPS (ttm) | -4.6900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 29.05B |
| Total cash per share (mrq) | 73.11 |
| Total debt (mrq) | 418.88B |
| Total debt/equity (mrq) | 268.28% |
| Current ratio (mrq) | 0.52 |
| Book value per share (mrq) | 392.82 |
Cash flow statement
| Operating cash flow (ttm) | -241.89B |
| Levered free cash flow (ttm) | -256.89B |
© 2024 Yahoo. All rights reserved.